Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTND4P33 is a pseudogene corresponding to the mitochondrial MT-ND4 gene, found within the nuclear genome. Pseudogenes are DNA sequences similar to normal genes but are generally nonfunctional due to mutations that prevent them from encoding a functional protein. MTND4P33 shares sequence similarity with the active MT-ND4 gene, which encodes a core subunit of mitochondrial complex I, a key enzyme in the electron transport chain and cellular energy production. However, as a pseudogene, MTND4P33 does not produce a functional protein and thus is not involved in normal mitochondrial or cellular functions. Nuclear mitochondrial pseudogenes (NUMTs), such as MTND4P33, can arise from the insertion of mitochondrial DNA into the nuclear genome, but these do not play direct roles in disease or serve as therapeutic targets[4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 pseudogene 33 (MTND4P33).